<p>Riociguat (A) and sildenafil (B) relax human pulmonary arteries (PA) bubbled with 21% O<sub>2</sub>-5% CO<sub>2</sub>-74% N<sub>2</sub>, 95% O<sub>2</sub>-5% CO<sub>2</sub> or with 95% N<sub>2</sub>-5% CO<sub>2</sub> (hypoxia). Arteries were initially stimulated with a cocktail of U46619 (30 nM), 5-HT (3 μM) and endothelin (3 nM) and, thereafter, the drugs were added in a cumulative fashion (all from 10<sup>-9</sup>M to 10<sup>-5</sup>M). Results are means ± SEM (n = 11 and 10 for riociguat and 7 and 6 for sildenafil). The parameters calculated from these curves and their statistical analysis are shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0191239#pone.0191239.t001" target="_blank">Table 1</a>.</p
<p>(A) Proportion of non-, partially or fully muscularized pulmonary arteries as a percentage of the...
Abstract It has been suggested that activation of nuclear peroxisome proliferator-activated receptor...
ObjectiveSildenafil is a pulmonary vasodilator that may reduce the decrement in endurance performanc...
<p>The sGC stimulators riociguat (A) and BAY412272 (B) and the PDE5 inhibitors sildenafil (C) and ta...
Introduction Current treatment with vasodilators for pulmonary hypertension associated with respirat...
BACKGROUND: Approved therapies for pulmonary arterial hypertension can induce oxygen desaturation wh...
Sildenafil is a pulmonary vasodilator that has potential to mitigate the decrement in endurance perf...
Background: Pulmonary hypertension is associated with poor outcome in patients with chronic heart fa...
Sildenafil is a pulmonary vasodilator that has potential to mitigate the decrement in endurance perf...
Current approved therapies for pulmonary hypertension (PH) aim to restore the balance between endoth...
Approved therapies for pulmonary arterial hypertension can induce oxygen desaturation when administe...
The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signal-t...
<p>(<b>A</b>, <b>C</b>) Double immunofluorescence staining for vWF (green signal) and α-SMA (red sig...
OBJECTIVE: We studied the effects of sildenafil, a phosphodiesterase 5 inhibitor, on coronary an...
Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by remodeling of the p...
<p>(A) Proportion of non-, partially or fully muscularized pulmonary arteries as a percentage of the...
Abstract It has been suggested that activation of nuclear peroxisome proliferator-activated receptor...
ObjectiveSildenafil is a pulmonary vasodilator that may reduce the decrement in endurance performanc...
<p>The sGC stimulators riociguat (A) and BAY412272 (B) and the PDE5 inhibitors sildenafil (C) and ta...
Introduction Current treatment with vasodilators for pulmonary hypertension associated with respirat...
BACKGROUND: Approved therapies for pulmonary arterial hypertension can induce oxygen desaturation wh...
Sildenafil is a pulmonary vasodilator that has potential to mitigate the decrement in endurance perf...
Background: Pulmonary hypertension is associated with poor outcome in patients with chronic heart fa...
Sildenafil is a pulmonary vasodilator that has potential to mitigate the decrement in endurance perf...
Current approved therapies for pulmonary hypertension (PH) aim to restore the balance between endoth...
Approved therapies for pulmonary arterial hypertension can induce oxygen desaturation when administe...
The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signal-t...
<p>(<b>A</b>, <b>C</b>) Double immunofluorescence staining for vWF (green signal) and α-SMA (red sig...
OBJECTIVE: We studied the effects of sildenafil, a phosphodiesterase 5 inhibitor, on coronary an...
Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by remodeling of the p...
<p>(A) Proportion of non-, partially or fully muscularized pulmonary arteries as a percentage of the...
Abstract It has been suggested that activation of nuclear peroxisome proliferator-activated receptor...
ObjectiveSildenafil is a pulmonary vasodilator that may reduce the decrement in endurance performanc...